Connect Biopharmaceuticals Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 62
Employees
  • Stock Symbol
  • CNTB
Stock Symbol
  • Share Price
  • $17.60
  • (As of Friday Closing)

Connect Biopharmaceuticals General Information

Description

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307, CBP-174, and CBP-233.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 3rd Floor, East R&D Building, Science and Technology Park
  • 6 Beijing West Road
  • Taicang, Jiangsu 214500
  • China
+86 0512 0000 0000

Connect Biopharmaceuticals Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Connect Biopharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.60 $17.63 $14.02 - $23.29 $1.01B 57.5M 158K -$2.02

Connect Biopharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
Revenue 0 0 0
EBITDA (112,679) (112,679) (24,437)
Net Income (112,790) (112,790) (24,404)
Total Assets 166,052 166,052 53,251
Total Debt 140 140 126
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Connect Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Connect Biopharmaceuticals‘s full profile, request access.

Request a free trial

Connect Biopharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation i
Drug Discovery
Taicang, China
62 As of 2021
00000
0000 0000-00-00
00000000 00000

0000000

iscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ven
0000 000000000
Beijing, China
0000 As of 0000
00.000
00000000000 00.000

00000000

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
0000000000000
San Francisco, CA
000 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Connect Biopharmaceuticals Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BeiGene Formerly PE-Backed Beijing, China 0000 00.000 00000000000 00.000
000000000 00000000 Formerly VC-backed San Francisco, CA 000 00000 000000&0 00000
000 000000000000 Formerly VC-backed Epalinges, Switzerland 000 00.000 00000000 00.000
00000000 Formerly VC-backed Tübingen, Germany 000 00000 000000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
You’re viewing 5 of 20 competitors. Get the full list »

Connect Biopharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
Wei Zheng Ph.D Co-Founder, Chief Executive Officer & Board Member
Eric Hall Interim Chief Financial Officer
Selwyn Ho MD Executive
Wubin Pan Ph.D Chairman & Founder
You’re viewing 4 of 6 executive team members. Get the full list »

Connect Biopharmaceuticals Board Members (10)

Name Representing Role Since
Derek DiRocco Ph.D RA Capital Management Board Member 000 0000
Derek DiRocco Self Board Member 000 0000
Jinghua Jin Advantech Capital Partners Board Member 000 0000
Kan Chen Ph.D Qiming Venture Partners Board Member 000 0000
Karen Wilson Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Connect Biopharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Connect Biopharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Connect Biopharmaceuticals‘s full profile, request access.

Request a free trial